About Us
- About Us
  - - - Historical Innovation
        View our Interactive Timeline
Therapies
- Therapies
  - - - We Are Committed to our Patients
        Clinical Trials
Research
- Research
  - - - Meet Our Scientists
        Brian
        Christel
        Gene
        Jamie
        Regina
        Vanita
Partnering
- Partnering
  - - - What we are looking for
    - - We are Committed to Success through Partnerships
Responsibility
- Responsibility
  - - - A Growing Community of Good Citizens
        Read the PharmaVoice Article
Media
- Media
Careers
- Careers
  - - - Learn more about working at EMD Serono
        Meet our Employees

Press Releases

2013
EMD Serono

2012
EMD Serono

2011
EMD Serono

2010
EMD Serono

2009
EMD Serono

2008
EMD Serono

2007
EMD Serono

2007
EMD Serono, Merck Serono S.A.

2013
04/15/2013	EMD Serono Expands Global Research & Development Hub in Massachusetts and Continues to Build Presence in US Pharmaceuticals Market Rockland, Massachusetts		English
04/15/2013	EMD Serono Announces Appeals Court Decision Rockland, Massachusetts		English
02/25/2013	EMD Serono: Phase III Trial of Cilengitide Did Not Meet Primary Endpoint in Patients With Newly Diagnosed Glioblastoma Rockland, Massachusetts		English
01/03/2013	EMD Serono and Pfizer Announce FDA Approval of Rebif^® Rebidose^® (interferon beta-1a) Rockland, Massachusetts/New York, NY		English

2012
12/20/2012	EMD Serono, Inc. and Fast Forward, LLC Announce Recipients of Funding for Multiple Sclerosis Research Rockland, Massachusetts		English
12/19/2012	EMD Serono: Phase III Trial of L-BLP25 (Stimuvax) in Patients with Non-Small Cell Lung Cancer Did not Meet Primary Endpoint Rockland, Massachusetts		English
10/18/2012	EMD Serono and Auxogyn Announce Collaboration on Eeva™ Test Rockland, Massachusetts		English
10/11/2012	EMD Serono Launches One Million Euro Research Grant for Multiple Sclerosis Innovation Rockland, Massachusetts		English
09/18/2012	EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include U.S. Investigators Rockland, Massachusetts		English
07/31/2012	EMD Serono Announces Appointment of Dr. Thorsten Eickenhorst to US Leadership Team Rockland, Massachusetts		English
06/14/2012	EMD Serono, Inc. Strengthens Leadership Teams with New Appointments Rockland, Massachusetts		English
05/23/2012	DR. ANNALISA JENKINS, EXECUTIVE VICE PRESIDENT, HEAD OF GLOBAL DRUG DEVELOPMENT AND MEDICAL FOR MERCK SERONO, HONORED BY GILDA’S CLUB NEW YORK CITY Rockland, Massachusetts		English
04/20/2012	EMD SERONO TO PRESENT NEW DATA ON MULTIPLE SCLEROSIS AT THE AMERICAN ACADEMY OF NEUROLOGY’S 64TH ANNUAL MEETING Rockland, Massachusetts		English
04/17/2012	EMD SERONO, INC. FOUNDING DONOR OF NEWLY LAUNCHED MGH MULTIPLE SCLEROSIS DISCOVERY FORUM Rockland, Massachusetts		English
01/23/2012	MS LIFELINES EARNS J.D. POWER AND ASSOCIATES CALL CENTER CERTIFICATION FOR CUSTOMER SERVICE EXCELLENCE IN PROVIDING SUPPORT SERVICES TO THE MS COMMUNITY Rockland, MA/New York, NY		English

2011
10/19/2011	EMD SERONO AND FAST FORWARD COMMIT $3 MILLION FOR MULTIPLE SCLEROSIS Rockland, Massachusetts		English
09/15/2011	EMD SERONO, INC. HONORED AS A 2011 WORKING MOTHER 100 BEST COMPANY Rockland, Massachusetts		English
07/14/2011	EMD SERONO, INC. ANNOUNCES APPOINTMENT OF JAMES HOYES AS PRESIDENT Rockland, Massachusetts		English
06/30/2011	EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE RECIPIENTS OF FUNDING FOR MULTIPLE SCLEROSIS RESEARCH Rockland, Massachusetts / New York, New York		English
06/23/2011	EMD SERONO INC. COMMITTED TO TRANSPARENCY IN INTERACTIONS WITH HEALTHCARE PROFESSIONALS AND ORGANIZATIONS Rockland, Massachusetts		English
06/09/2011	EMD SERONO: PATIENT ENROLLMENT COMPLETED FOR CILENGITIDE'S PIVOTAL PHASE III TRIAL CENTRIC Rockland, Massachusetts		English
05/20/2011	EMD SERONO PRESIDENT AND CEO FEREYDOUN FIROUZ RESIGNS Rockland, Massachusetts		English
05/04/2011	EMD SERONO, INC. ANNOUNCES CIVIL SETTLEMENT Rockland, Massachusetts		English
04/28/2011	EMD SERONO, INC. PROVIDES $1.5M GRANT TO MASSACHUSETTS GENERAL Rockland, Massachusetts		English
04/26/2011	EMD SERONO, INC. RECEIVES GOLD LEED RATING Rockland, Massachusetts		English
04/08/2011	EMD SERONO'S COMMITMENT TO ADVANCE MULTIPLE SCLEROSIS CARE AND RESEARCH UNDERSCORED BY DATA TO BE PRESENTED AT AAN 2011 MEETING Rockland, Massachusetts		English
03/24/2011	EMD SERONO, INC. RECEIVES CEO CANCER GOLD STANDARD™ ACCREDITATION Rockland, Massachusetts		English
03/02/2011	EMD SERONO RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION Rockland, Massachusetts		English
02/10/2011	EMD SERONO HOLDS GRAND OPENING CEREMONY FOR NEW STATE-OF-THE-ART RESEARCH CENTER IN BILLERICA, MA Rockland, Massachusetts		English

2010
11/26/2010	EMD SERONO ANNOUNCES EXTENSION OF FDA PRIORITY REVIEW PERIOD FOR CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS Rockland, Massachusetts		English
11/11/2010	FDA APPROVES EGRIFTA (TESAMORELIN FOR INJECTION): FIRST AND ONLY TREATMENT FOR THE REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY Rockland, Massachusetts		English
10/08/2010	EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Rockland, Massachusetts		English
09/01/2010	MS LIFELINES REACHES MILESTONE OF SERVICING ONE MILLION IN-BOUND CALLS Rockland, Massachusetts		English
07/28/2010	EMD SERONO, INC.: FDA GRANTS PRIORITY REVIEW TO CLADRIBINE TABLETS FOR THE TREATMENT OF RELAPSING FORMS OF MS Rockland, Massachusetts		English
06/17/2010	EMD SERONO RESUMES STIMUVAX CLINICAL PROGRAM IN LUNG CANCER Rockland, Massachusetts		English
06/05/2010	CILENGITIDE STUDY PROVIDES LONG-TERM FOLLOW-UP DATA IN GLIOBLASTOMA PATIENTS Rockland, Massachusetts		English
05/05/2010	EMD SERONO, INC. AND FAST FORWARD, LLC ANNOUNCE FIRST RESULTS OF THEIR COLLABORATION TO ADVANCE DRUG DEVELOPMENT IN MULTIPLE SCLEROSIS Rockland, Massachusetts		English
03/23/2010	EMD SERONO: STIMUVAX CLINICAL PROGRAM TEMPORARILY SUSPENDED Geneva, Switzerland		English
03/05/2010	EMD SERONO, INC. NAMED ONE OF THE BEST PLACES TO WORK IN INDUSTRY BY THE SCIENTIST MAGAZINE Rockland, Massachusetts		English
1/21/2010	TWO-YEAR RESULTS FROM CLARITY STUDY WITH CLADRIBINE TABLETS IN MULTIPLE SCLEROSIS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE Rockland, Massachusetts		English

2009
12/16/2009	EMD SERONO, INC. AND NATIONALLY RANKED US HOSPITAL ANNOUNCE COLLABORATION IN BASIC AND CLINICAL RESEARCH IN MULTIPLE SCLEROSIS Rockland, MA		English
11/30/2009	EMD SERONO, INC. RECEIVES REFUSE TO FILE LETTER FROM FDA ON CLADRIBINE TABLETS NEW DRUG APPLICATION Rockland, MA		English
10/19/2009	EMD SERONO, INC. HOLDS TOPPING OFF CEREMONY TO MARK MILESTONE IN EXPANSION OF THE COMPANY'S BILLERICA, MA RESEARCH FACILITY Rockland, MA		English
10/05/2009	EMD SERONO, INC. NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Rockland, MA		English
09/30/2009	EMD SERONO SUBMITS APPLICATION FOR CLADRIBINE TABLETS AS A POTENTIAL ORAL SHORT-COURSE MULTIPLE SCLEROSIS THERAPY IN THE UNITED STATES Rockland, MA		English
08/10/2009	EMD SERONO, INC. AND THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER ANNOUNCE COLLABORATION FOR PRECLINICAL RESEARCH, CLINICAL TRIALS Rockland, MA/Houston, TX		Englis h
05/27/2009	MULTIPLE SCLEROSIS - WHAT ARE PEOPLE WITH MS AND THEIR HEALTH CARE PROVIDERS REALLY THINKING? Rockland, MA/New York, NY		English
05/01/2009	EMD Serono, Inc. and Fast Forward, LLC Commit $3 Million in 2009 To Early Stage Drug Development For Multiple Sclerosis Rockland, MA/New York, NY		English
04/29/2009	TWO-YEAR PHASE III DATA PRESENTED AT AAN 61ST ANNUAL MEETING SHOW POSITIVE OUTCOME OF CLADRIBINE TABLETS IN PATIENTS WITH MULTIPLE SCLEROSIS Rockland, Massachusetts		English
03/30/2009	EMD SERONO: NEW PHASE III DATA FOR CLADRIBINE TABLETS TO BE PRESENTED AT THE AMERICAN ACademY OF NEUROLOGY 61ST ANNUAL MEETING IN APRIL 2009 Rockland, Massachusetts		English
03/30/2009	EMD SERONO ANNOUNCES EXPANSION WITH RESEARCH SITE IN CAMBRIdGE, MASSACHUSETTS Rockland, Massachusetts		English
03/18/2009	EMD SERONO and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis Rockland, Massachusetts		English
01/23/2009	EMD SERONO’S ORAL INVESTIGATIONAL TREATMENT CLADRIBINE TABLETS FOR MULTIPLE SCLEROSIS SIGNIFICANTLY REDUCED RELAPSE RATE IN TWO-YEAR PHASE III PIVOTAL TRIAL Rockland, Massachusetts		English
01/12/2009	EMD Serono and Emmaus Medical Announce Promotional Rights Agreement for Zorbtive® in the United States Rockland, Massachusetts		English

2008
11/07/2008	EMD SERONO LAUNCHES LANDMARK PATIENT REGISTRY FOR EGG FREEZING Rockland, Massachusetts		English
10/29/2008	EMD SERONO AND THERATECHNOLOGIES ANNOUNCE COLLABORATION AND LICENSING AGREEMENT FOR TESAMORELIN IN THE UNITED STATES Rockland, Massachusetts		English
10/9/2008	EMD SERONO NAMED AS A TOP EMPLOYER BY SCIENCE MAGAZINE Rockland, Massachusetts		English
7/10/2008	EMD SERONO, INC. TO ADOPT REVISED AND STRENGTHENED PHRMA CODE Rockland, Massachusetts		English
4/16/2008	EMD SERONO ANNOUNCES PLANNED INVESTMENT OF $50 MILLION IN RESEARCH CENTER IN MASSACHUSETTS Geneva, Switzerland		English

2007
12/13/2007	EMD ANNOUNCES SUPPORT OF THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH Geneva, Switzerland		English
12/6/2007	EMD SERONO LAUNCHES EASYPOD®, NEW ELECTRONIC GROWTH HORMONE INJECTION DEVICEGeneva, Switzerland		English
7/2/2007	EMD SERONO LAUNCHES MS LIFELINES ACCESS MADE SIMPLE, A PROGRAM DESIGNED TO SIMPLIFY ACCESS TO MS THERAPY Rockland, Massachusetts		English

2007
6/4/2007	MERCK SERONO S.A. TO TERMINATE REGISTRATION AND DUTY TO FILE REPORTS UNDER THE U.S. SECURITIES EXCHANGE ACT Geneva, Switzerland		English
6/4/2007	CLOSING OF THE EXISTING SHARE-REPURCHASE PROGRAM OF UP TO CHF 750 MILLION BY JUNE 1, 2007 Geneva, Switzerland		English
4/5/2007	MERCK SERONO S.A. TO VOLUNTARILY DELIST AND DEREGISTER ITS BEARER SHARES AND AMERICAN DEPOSITARY SHARES (EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS) Geneva, Switzerland		English
3/21/2007	MERCK INITIATES SQUEEZE OUT PROCEDURE FOR SHARES OF MERCK SERONO S.A. Geneva, Switzerland		English
3/21/2007	MERCK SERONO CONFIRMS PREVIOUSLY ANNOUNCED 2006 FIGURES Geneva, Switzerland		English
2/28/2007	MERCK KGAA HOLDS NEARLY ALL VOTING RIGHTS IN MERCK SERONO S.A. Geneva, Switzerland		English
1/9/2007	MERCK KGaA ANNOUNCES PUBLIC TENDER OFFER FOR MERCK SERONO SHARES Geneva, Switzerland		English
1/8/2007	MERCK SERONO IS LAUNCHED Geneva, Switzerland		English
1/5/2007	MERCK KGAA ACQUIRES MARJORITY SHAREHOLDING IN SERONO S.A. Geneva, Switzerland		English

top

MEDIA CONTACT

Tel.: 781-681-2468

Send us an e-mail

MEDIA KIT

Access PDF files and images relating to company facts, our leadership team, EMD Serono locations, and our therapeutic areas.

Interactive Media Kit

SERVICES

Request Medical Information

Print Page